Metabolic syndrome and chronic kidney disease in a rural Chinese population

Clinica Chimica Acta

Volumn 412, Issue 21-22, 2011, Pages 1983-1988

  Jiang, LiPing ^a   Liang, YuanBo ^a   Qiu, Bo ^a   Wang, FengHua ^a   Duan, XinRong ^a   Yang, XiaoHui ^a   Yang, JinGang ^b   Huang, Wen ^a   Wang, NingLi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

China; Chronic kidney disease; Epidemiology; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RURAL HEALTH; RURAL POPULATION;

EID: 80051704520     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.014     Document Type: Article

References (40)

1. Meguid El, Nahas A., Bello A.K. Chronic kidney disease: the global challenge. Lancet 2005, 365:331-340.
2. Go A.S., Chertow G.M., Fan D., Mc Culloch C.E., Hsu C. Chronic kidney disease and the risks of death, cardio-vascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Muntner P., He J., Hamm L., Loria C., Whelton D.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002, 13:745-753.
4. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification and stratification. Am J Kidney Dis 2002, 39:S1-S266.
5. Xue J.L., Ma J.Z., Louis T.A., Collins A.J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001, 12:2753-2758.
6. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
7. Gu D., Reynolds K., Wu X., et al. InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365:1398-1405.
8. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004, 140:167-174.
9. Kurella M., Lo J.C., Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16:2134-2140.
10. Ninomiya T., Kiyohara Y., Kubo M., et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006, 48:383-391.
11. Tanaka H., Shiohira Y., Uezu Y., Higa A., Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006, 69:369-374.
12. Zhang L., Zuo L., Wang F., et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40years and older. Mayo Clin Proc 2007, 82:822-827.
13. Lin C.C., Liu C.S., Li T.C., Chen C.C., Li C.I., Lin W.Y. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest 2007, 37:783-790.
14. Gao D., Liu Z.S., Liu D.W., et al. Association of metabolic syndrome and chronic kidney disease in Zhengzhou adults. Clin J Endocrinol Metab 2009, 25:414-415.
15. Chen B., Yang D., Chen Y., Xu W., Ye B., Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta 2010, 41:705-709.
16. National Bureau of Statistics of China The National Sample Survey on 1% of Population in 2005 http://www.stats.gov.cn/tjgb/rkpcgb/qgrkpcgb/t20060316_402310923.htm.
17. Jiang L., Liang Y., Qiu B., et al. Prevalence of chronic kidney disease in a rural Chinese adult population: the Handan Eye Study. Nephron Clin Pract 2010, 114:295-302.
18. Liang Y.B., Friedman D.S., Wong T.Y., et al. Prevalence and cause of low vision and blindness in a rural Chinese adult population: the Handan eye study. Ophthalmology 2008, 115:1965-1972.
19. Expert Panel on Metabolic Syndrome of Chinese Diabetes Society. Recommendations on metabolic syndrome of Chinese Diabetes Society (Chinese). Chin J Diab 2004, 12:156-161.
20. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol 2007, 390-419.
21. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
22. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17:2937-2944.
23. Chang I.H., Han J.H., Myung S.C., et al. Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology 2009, 14:321-326.
24. Kitiyakara C., Yamwong S., Cheepudomwit S., et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007, 71:693-700.
25. Chen J., Gu D., Chen C.S., et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007, 22:1100-1106.
26. Sun F., Tao Q., Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118,924 non-diabetic Taiwanese in a retrospective cohort. Nephrology 2010, 15:84-92.
27. Zhang L.X., Zhang P.H., Wang F., et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008, 51:373-384.
28. Chen W., Wang H., Dong X., et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 2009, 24:1205-1212.
29. Chen J., Wildman R.P., Gu D., et al. Prevalence of chronic kidney disease in Chinese adult population. Kidney Int 2005, 68:2837-2845.
30. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
31. Zhang L., Zuo L., Wang F., et al. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol 2006, 17:2617-2621.
32. Hsu C.Y., Mc Culloch C.E., Darbinian J., Go A.S. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005, 165:923-928.
33. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
34. Muntner P., Coresh J., Smith J.C., Eckfeldt J., Klag M.J. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000, 58:293-301.
35. Vupputuri S., Sandler D.P. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 2003, 13:712-720.
36. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004, 65:1870-1876.
37. Gelber R.P., Kurth T., Kausz A.T., et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005, 46:871-880.
38. Shankar A., Leng C., Chia K.S., et al. Association between body mass index and chronic kidney disease in men and women: population based study of Malay adults in Singapore. Nephrol Dial Transplant 2008, 23:1910-1918.
39. Molitch M.E., DeFronzo R.A., Franz M.J., et al. Diabetic nephropathy. Diabetes Care 2003, 26:S94-S98.
40. Rule A.D., Rodeheffer R.J., Larson T.S., et al. Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc 2006, 81:1427-1434.